<?xml version="1.0" encoding="UTF-8"?>
<results title="activity">
 <result pre="these terms. Abstract In recent years, the demand for novel" exact="antifungal" post="therapies has increased several- folds due to its potential"/>
 <result pre="characteristics and intrinsic resistance from both host immune response and" exact="antimicrobial" post="drugs. Candida albicans biofilm is a complex association of"/>
 <result pre="using different nanomaterials against C. albicans. Candida albicans biofilm resistance" exact="antifungal" post="drugs prostaglandins small molecule inhibitors naturally occurring compounds fig-count:"/>
 <result pre="nanomaterials against C. albicans. Candida albicans biofilm resistance antifungal drugs" exact="prostaglandins" post="small molecule inhibitors naturally occurring compounds fig-count: table-count: equation-count:"/>
 <result pre="â€œinhabitants,â€� fungi and bacteria, are less sensitive or insensitive to" exact="antimicrobial" post="agents. The property of the microorganisms to adhere to"/>
 <result pre="in the morphology extracellular matrix (ECM), and potential to resist" exact="antifungal" post="drugs (Cavalheiro and Teixeira, 2018). National Nosocomial Infection Survey"/>
 <result pre="a well-connected global human population has increased the cases of" exact="antimicrobial" post="resistance (Michael et al., 2014). According to the UN"/>
 <result pre="to that of the 2008-2009 global financial recession. By 2030," exact="antimicrobial" post="resistance could affect approximately 24 million people plunging them"/>
 <result pre="the ever -growing human population. Owing to its inappropriate use," exact="antifungal" post="drug resistance has emerged as a major challenge that"/>
 <result pre="polyenes, pyrimidine analogs, and echinocandins. The primary targets of these" exact="antifungal" post="drugs are the biosynthetic pathway of ergosterol, the cell"/>
 <result pre="FIGURE 1 A different mechanism of actions of commonly known" exact="antifungal" post="drugs adapted from Spampinato and Leonardi (2013). Azoles are"/>
 <result pre="adapted from Spampinato and Leonardi (2013). Azoles are widely recommended" exact="antifungal" post="drugs to treat superficial and invasive fungal infections. The"/>
 <result pre="are the FDA- approved broad -spectrum third generation azole- based" exact="antifungal" post="drugs. They exhibit their antifungal effects by inhibiting cytochrome"/>
 <result pre="-spectrum third generation azole- based antifungal drugs. They exhibit their" exact="antifungal" post="effects by inhibiting cytochrome P450-dependent 14Î±-lanosterol demethylase (Cyp51) encrypted"/>
 <result pre="arrest. The 5-FC in itself does not act as an" exact="antifungal" post="agent but becomes active when changed into 5-fluorouracil. This"/>
 <result pre="inside the host cells. Even with a vast diversity of" exact="antifungal" post="drugs, the problem of resistance persists against the drug"/>
 <result pre="the range of treatment. Thus, the indispensable development of new" exact="antifungal" post="therapies with high efficiency against the biofilm mode of"/>
 <result pre="is required. Biofilms are the major contributors and intensifiers of" exact="antifungal" post="resilience. As yet, none of these factors works alone."/>
 <result pre="As yet, none of these factors works alone. Instead, this" exact="antifungal" post="resilience is a multifactorial phenomenon, which is still unexplored."/>
 <result pre="matrix, the existence of persister cells, gene expression of the" exact="antifungal" post="resistance genes, and the proliferation of sterols on the"/>
 <result pre="guards the adherent cells against the host immune system and" exact="antifungal" post="agents by forming an extensive structure of the matrix"/>
 <result pre="the adherent cells against the host immune system and antifungal" exact="agents" post="by forming an extensive structure of the matrix (Borghi"/>
 <result pre="in biofilms is Msb2. This protein secretes and blocks the" exact="antimicrobial" post="peptides preventing complement activation. Neutrophils are the first foot"/>
 <result pre="transient viscosity of mucosal layers, and indiscriminate usage of broad-spectrum" exact="antimicrobial" post="agents- lead to the disproportionate infection by the overgrowth"/>
 <result pre="of efflux pumps is one of the major contributors to" exact="antifungal" post="drug resistance in C. albicans as they lead to"/>
 <result pre="as they lead to drug sequestration by pumping out the" exact="antifungal" post="drugs given as a treatment. Subsequently, these are primarily"/>
 <result pre="with first-generation azoles but ineffective toward Echinocandins resistance. During usual" exact="antifungal" post="treatment toward planktonic cells, efflux pumps prevent the intracellular"/>
 <result pre="toward planktonic cells, efflux pumps prevent the intracellular accumulation of" exact="antifungal" post="drugs by up-regulating their expression (Borghi et al., 2016;"/>
 <result pre="through the biofilm growth even in the absence of the" exact="antifungal" post="drug. Rapid upregulation of efflux pumps happens during the"/>
 <result pre="of C. albicans biofilm displays increased resistance to the available" exact="antifungal" post="drugs. These persistent groups of cells are difficult to"/>
 <result pre="Different targets have gained attention aiming to tackle this growing" exact="antifungal" post="resistance problem. Treating these biofilms is a big hurdle"/>
 <result pre="there is a vast exigency for the development of new" exact="antifungal" post="agents and identification of novel targets. Considering the efforts"/>
 <result pre="is a vast exigency for the development of new antifungal" exact="agents" post="and identification of novel targets. Considering the efforts undertaken"/>
 <result pre="on biofilms have revealed the important role of lipids on" exact="antifungal" post="resistance. The lipid profile of planktonic cells differs from"/>
 <result pre="et al., 2018; Su et al., 2018). Thus exploiting these" exact="prostaglandins" post="adaptation and their properties could be targeted for treatment."/>
 <result pre="cyclooxygenase enzymes in human cells as well as pathogenic fungi." exact="Prostaglandin" post="E2 is the profusely synthesized prostaglandin that transfers immune"/>
 <result pre="well as pathogenic fungi. Prostaglandin E2 is the profusely synthesized" exact="prostaglandin" post="that transfers immune responses of humans in the direction"/>
 <result pre="Th-1 is accountable for pro-inflammatory responses, while Th-2 for producing" exact="anti-inflammatory" post="responses (Berger, 2000). PGE2 also down-regulates the production of"/>
 <result pre="and germ tube formation. Arachidonic acid, when used along with" exact="antifungal" post="drugs, affects the level of prostaglandin E2 in a"/>
 <result pre="when used along with antifungal drugs, affects the level of" exact="prostaglandin" post="E2 in a variety of Candida spp. The above-mentioned"/>
 <result pre="bloodstream infections (CLABSIs), removal of the devices and providing systemic" exact="antimicrobial" post="therapy was performed to eradicate these microorganisms. These biomedical-assisted"/>
 <result pre="the antibiotic used for planktonic cells in combination with the" exact="anticoagulant" post="instilled into the lumen of a catheter. The solution"/>
 <result pre="therapy compared to 33% of the patients treated with systemic" exact="antimicrobial" post="drugs (Oâ€™Horo et al., 2011). Ethanol Lock solution at"/>
 <result pre="C. albicans biofilm metabolism (Alonso et al., 2018). Small Molecular" exact="Inhibitors" post="and Natural Products Microbiological resistance depends on various fungal"/>
 <result pre="one way to avoid resistance is the use of combinational" exact="antifungal" post="therapy. Combination therapy also offers advantages in increased synergistic"/>
 <result pre="of drug resistance will help in the development of appropriate" exact="antifungal" post="therapy. For dealing with this problem of resistance, there"/>
 <result pre="repurposing of the known drug to increase the activity of" exact="antifungal" post="agents by combinational therapy. Due to the scarcity of"/>
 <result pre="of the known drug to increase the activity of antifungal" exact="agents" post="by combinational therapy. Due to the scarcity of known"/>
 <result pre="A high-content screen has identified many new structural series of" exact="antifungal" post="compounds with the mode of action, namely inhibition of"/>
 <result pre="minimizing the development of resistance. Different Targets of Small Molecule" exact="Inhibitors" post="Small molecular inhibitors have been identified specifically for various"/>
 <result pre="MIC/IC50 values which are summarized in the tables mentioned below." exact="Inhibitors" post="of budded to hyphal transition The pathogenic yeast C."/>
 <result pre="yeast-to-hypha transition, Sm21 6 was identified as a novel small" exact="antifungal" post="molecule that showed its efficacy in both in vivo"/>
 <result pre="to be a strong candidate for future investigation as an" exact="antifungal" post="agent (Manoharan et al., 2017b). While performing high throughput"/>
 <result pre="Niclosamide 11 which is the analog of salicylanilide, an FDA-approved" exact="anthelmintic" post="in humans, both exhibiting an anti-filamentation and anti-biofilm activities"/>
 <result pre="an anti-filamentation drug which acts as an potentiate a known" exact="antifungal" post="drug Clotrimazole by increasing its activity to &amp;gt;100 fold"/>
 <result pre="in humans, ASADH can be a promising new target for" exact="antifungal" post="research. Deleting the ASD gene encoding for ASADH significantly"/>
 <result pre="Viola, 2018; Dahal et al., 2020). The 1,4-Napthoquinone and its" exact="derivatives" post="15, 15 (c-e) did possess activity against clinical isolates"/>
 <result pre="characteristics. So from the studies, compound 16, one of the" exact="derivatives" post="of pepstatin, came out to be a potent inhibitor"/>
 <result pre="27 and 38% respectively. Efflux pump One of the structural" exact="derivatives" post="of cyclobutene-dione [3-(phenylamino)-4-{[1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]methyl}-cyclobut-3-ene-1,2-dione] 19 was chemically synthesized and was"/>
 <result pre="observed that compound 20 is in synergism with already known" exact="antifungal" post="drugs augmenting the accumulation of ROS, leading to early"/>
 <result pre="2.5 Î¼M (Wall et al., 2018). Furthermore, it elucidates its" exact="antifungal" post="activity by accumulating reactive oxygen species (ROS) inside the"/>
 <result pre="FDA Approved Drug Showing Synergistic Effect Haloperidol 49 and its" exact="derivative" post="(Benzocyclane derivative B10 49a) (Ji et al., 2020) and"/>
 <result pre="Drug Showing Synergistic Effect Haloperidol 49 and its derivative (Benzocyclane" exact="derivative" post="B10 49a) (Ji et al., 2020) and Bromoperidol 50"/>
 <result pre="49a) (Ji et al., 2020) and Bromoperidol 50 and its" exact="derivative" post="are some of the known antipsychotic drugs that were"/>
 <result pre="that were repurposed and were utilized as anti-biofilm molecules. Haloperidolâ€™s" exact="derivative" post="exhibited inhibition of yeast to hyphal transition in resistant"/>
 <result pre="in murine model of invasive candidiasis. Similarly, Bromoperidol and its" exact="derivative" post="showed a synergistic effect in combination with different azoles."/>
 <result pre="the fungal strains toward azole- as the first line of" exact="antifungal" post="drugs. Piperazinyl quinolone 51 screened from MLPCN library had"/>
 <result pre="drugs. Piperazinyl quinolone 51 screened from MLPCN library had no" exact="antifungal" post="activity alone, but, in combination with Azoles, it selectively"/>
 <result pre="illustrated the increase in the susceptibility of C. albicans toward" exact="antifungal" post="drugs (Uppuluri et al., 2008; Cordeiro et al., 2014;"/>
 <result pre="al., 2014; Jia et al., 2016). Ribavirin 54, already known" exact="antiviral drug," post="was screened through Prestwick Chemical Library against FLC-resistant strains."/>
 <result pre="dihydroartemisinin and other artemisinin derivatives, indicating artemisinin as a potential" exact="antifungal" post="molecule that can be further investigated to establish its"/>
 <result pre="synergistic effect on C. elegans infection model, it showed strong" exact="antifungal" post="potency (Delattin et al., 2014). Diclofenac 69 a non"/>
 <result pre="potency (Delattin et al., 2014). Diclofenac 69 a non -steroidal" exact="anti-inflammatory" post="drug, increased the susceptibility of caspofungin toward the in"/>
 <result pre="the most common and productive methodologies to obtain novel therapeutic" exact="agents" post="using medicinal chemistry (Zaki et al., 2019). Thus, targeting"/>
 <result pre="et al., 2019). Thus, targeting fungal biofilms by either natural" exact="derivatives" post="or synthetic analogs could be a novel approach. Natural"/>
 <result pre="proved to be one of the promising strategies. Although anti-biofilm" exact="agents" post="themselves might not kill the bacteria, they can make"/>
 <result pre="A Recent study shows that compound 70 and 71 are" exact="antifungal" post="and induce ROS mediated programmed cell death in C."/>
 <result pre="a total of 12 different saponins were identified as potential" exact="antifungal" post="agents, but out of those 12, only two were"/>
 <result pre="family of the saponins. Both of these compounds were potent" exact="antifungal" post="agents with MIC 16 and 32 Î¼g/ml, respectively. Furthermore,"/>
 <result pre="of the saponins. Both of these compounds were potent antifungal" exact="agents" post="with MIC 16 and 32 Î¼g/ml, respectively. Furthermore, to"/>
 <result pre="genes thus, inhibiting hyphal formation. Additionally, one of the semi-synthetic" exact="derivative" post="of Riccardin D with a bromine atom attached to"/>
 <result pre="a bromine atom attached to the arene ring showed better" exact="antifungal" post="activity with MIC-2 Î¼g/ml in comparison to Riccardin with"/>
 <result pre="(3, 4, 5 -trihydroxystilbene) 84 is a phytoalexin, a known" exact="antimicrobial agent" post="present in a wide range of dietary sources, including"/>
 <result pre="albicans strain. Subsequently, the study revealed that resveratrol regulates its" exact="antifungal" post="activity from early to late apoptosis stage. Furthermore, it"/>
 <result pre="oils from plants and their compounds have been scrutinized as" exact="antifungal" post="agents. The essential oil of Coriandrum sativum delineates fungicidal"/>
 <result pre="a compound extracted from Rumex roots, were defined as anti-biofilm" exact="agents" post="against C. albicans. It also increased the survivability in"/>
 <result pre="Brazilian Organic Propolis â€&quot;BOP6 crude extract was characterized as an" exact="anti-inflammatory" post="and anti-biofilm agent. It reduces the mortality rate by"/>
 <result pre="eucalyptus oil and its component 1, 8- cineole 106 showed" exact="antimicrobial" post="activity against different microbes including C. albicans biofilm. It"/>
 <result pre="essential oils as a treatment against invasive candidiasis, some terpenic" exact="derivatives" post="showed promising results. These include carvacrol 73, geraniol 75,"/>
 <result pre="114. On further study, tyrosol 115 â€&quot;(a phenethyl alcohol), tyrosine" exact="derivative" post="and eugenol- phenylpropanoid 116 both showed a strong inhibitory"/>
 <result pre="camphoratus and T. carnosus, earlier used in Portuguese as an" exact="antimicrobial" post="therapy, lead to the discovery of different molecules. In"/>
 <result pre="A recent study revealed that compound 123 and 124 regulated" exact="antifungal" post="activity against C. albicans by ROS mediated apoptosis (Chen"/>
 <result pre="sphingosine precursors. It works very effectively in combination with known" exact="antifungal" post="drugs like amphotericin and fluconazole, reducing the mortality rate"/>
 <result pre="vivo study of acetylcholine on G. mellonella larvae showed robust" exact="antifungal" post="potency with a decrease in mortality rate from 80"/>
 <result pre="B 137, 137(a-b) a naturally derived azaoxoporphine alkaloid and its" exact="derivatives" post="showed potent activity against C. albicans biofilms and yeast"/>
 <result pre="and yeast to hyphal formation. It was found to show" exact="antifungal" post="activity by inducing the accumulation of ROS and subsequent"/>
 <result pre="and subsequent heme dysfunction. Moreover, it showed strong in vivo" exact="antifungal" post="activity with low cytotoxicity in nematode model of C."/>
 <result pre="Moreover, it showed strong in vivo antifungal activity with low" exact="cytotoxicity" post="in nematode model of C. albicans (Wu et al.,"/>
 <result pre="article, we have seen different strategies and methods to combat" exact="antifungal" post="drug resistance. However, after all the efforts and attempts"/>
 <result pre="biofilm formation is difficult to treat with both non-antifungal and" exact="antifungal" post="drugs because of the poor penetration and non-specificity of"/>
 <result pre="to treat microbial infections pertaining to their strong potential as" exact="antimicrobial" post="agents. In this context, different research groups have initiated"/>
 <result pre="C. albicans (Shukla, 2020). The usage of silver as an" exact="antimicrobial agent" post="spans a century. Silver was used as a disinfectant"/>
 <result pre="antimicrobial agent spans a century. Silver was used as a" exact="disinfectant" post="by Greeks and Romans to decontaminate their water and"/>
 <result pre="Recently, researchers have identified bismuth oxide (BiO3) nanoparticles with potent" exact="antimycotic" post="activity against C. albicans growth. Moreover, when these nanoparticles"/>
 <result pre="growth. Moreover, when these nanoparticles were compared to commercially available" exact="antifungal" post="drugs like chlorhexidine, nystatin, they completely eradicated the biofilm"/>
 <result pre="magnesium oxide nanoparticles (MgO NP) were used to investigate their" exact="antifungal" post="and antibiofilm property against C. albicans. The study revealed"/>
 <result pre="chitostan and its nanoparticle (ChNPs) were already known for their" exact="antifungal" post="property (Ing et al., 2012; Mohammed et al., 2017;"/>
 <result pre="2017). The titanium oxide nanoparticles (Ti-NP) when scrutinized for their" exact="antifungal" post="property showed strong antifungal activity against planktonic form of"/>
 <result pre="nanoparticles (Ti-NP) when scrutinized for their antifungal property showed strong" exact="antifungal" post="activity against planktonic form of C. albicans. They also"/>
 <result pre="copper oxide nanoparticles, CuONP was more stable and depicted better" exact="antifungal" post="activity in comparison to Cu2O-NP (Rasool, 2019; Padmavathi et"/>
 <result pre="The nitric oxide nanoparticles (NO-NP) showed strong potential as an" exact="antifungal" post="agent by hindering the extracellular matrix and biofilm formation"/>
 <result pre="a progressively alarming problem, this warrants the development of new" exact="antifungal" post="agents and the search for newer targets. This review"/>
 <result pre="progressively alarming problem, this warrants the development of new antifungal" exact="agents" post="and the search for newer targets. This review elucidates"/>
 <result pre="pathogenic foundation and molecular mechanism of C. albicans biofilms over" exact="antifungal" post="drug resistance. A plethora of studies by several scientific"/>
 <result pre="formation. Recently, different metal nanoparticles have also emerged as antibiofilm" exact="agents" post="against C. albicans and gaining momentum. Furthermore, different combinational"/>
 <result pre="a target is mounted. Given the diverse strategies to combat" exact="antifungal" post="resistance, there is a hope that specific target-based drugs"/>
 <result pre="Infect.100e187â€&quot;e195. 10.1016/j.jhin.2018.04.00729653134 AlvesM.GonÃ§alvesM. J.ZuzarteM.Alves-SilvaJ. M.CavaleiroC.CruzM. T.et al. (2019). Unveiling the" exact="antifungal" post="potential of two Iberian thyme essential oils: effect on"/>
 <result pre="E. E.NorrisL. B.EdwardsJ. M.SherertzR. J. (2013). Stability and compatibility of" exact="antimicrobial" post="lock solutions.Am. J. Heal. Pharm.702185â€&quot;2198. 10.2146/ajhp12011924296841 BorghiE.BorgoF.MoraceG. (2016). Fungal"/>
 <result pre="species complex.J. Med. Microbiol.63(Pt 7)936â€&quot;944. 10.1099/jmm.0.073478-024722799 CrettonS.DorsazS.AzzolliniA.Favre-godalQ.MarcourtL.EbrahimiS. N.et al. (2016)." exact="Antifungal" post="quinoline alkaloids from Waltheria indica.J. Nat. Prod.79300â€&quot;307. 10.1021/acs.jnatprod.5b0089626848627 DahalG."/>
 <result pre="de CastroR. D.de SouzaT. M.BezerraL. M.FerreiraG. L.CostaE. M.CavalcantiA. L. (2015)." exact="Antifungal" post="activity and mode of action of thymol and its"/>
 <result pre="in infection.Trends Microbiol.1130â€&quot;36. 10.1016/S0966-842X(02)00002-112526852 EndoE. H.CortezD. A.Ueda-NakamuraT.NakamuraC. V.PradoB.FilhoD. (2010). Potent" exact="antifungal" post="activity of extracts and pure compound isolated from pomegranate"/>
 <result pre="Candida albicans.Res. Microbiol.161534â€&quot;540. 10.1016/j.resmic.2010.05.00220541606 Erb-DownwardJ. R.NoverrM. C. (2007). Characterization of" exact="prostaglandin" post="E2 production by Candida albicans.Infect. Immun.753498â€&quot;3505. 10.1128/IAI.00232-0717470538 EvensenN. A.BraunP."/>
 <result pre="morphogenesis, and pathogenesis.Proc. Natl. Acad. Sci. U.S.A.11013594â€&quot;13599. 10.1073/pnas.130598211023904484 FeldmanM.Al-QuntarA.PolacheckI.FriedmanM.SteinbergD. (2014)." exact="Therapeutic" post="potential of thiazolidinedione-8 as an antibiofilm agent against Candida"/>
 <result pre="development, regulation, and molecular mechanisms.Microbes Infect.18310â€&quot;321. 10.1016/j.micinf.2016.01.00226806384 HaghighiF.MohammadiS. R.MohammadiP.HosseinkhaniS.ShidpourR. (2013)." exact="Antifungal" post="Activity of TiO 2 nanoparticles and EDTA on Candida"/>
 <result pre="HawserS. P.DouglasL. J. (1995). Resistance of Candida albicans biofilms to" exact="antifungal" post="agents in vitro.Antimicrob. Agents Chemother.392128â€&quot;2131. 10.1128/AAC.39.9.21288540729 HendryE. R.WorthingtonT.ConwayB. R.LambertP."/>
 <result pre="P.DouglasL. J. (1995). Resistance of Candida albicans biofilms to antifungal" exact="agents" post="in vitro.Antimicrob. Agents Chemother.392128â€&quot;2131. 10.1128/AAC.39.9.21288540729 HendryE. R.WorthingtonT.ConwayB. R.LambertP. A."/>
 <result pre="HolbrookS. Y. L.GarzanA.DennisE. K.ShresthaS. K.Garneau-TsodikovaS. (2017). Repurposing antipsychotic drugs into" exact="antifungal" post="agents: synergistic combinations of azoles and bromperidol derivatives in"/>
 <result pre="drugs into antifungal agents: synergistic combinations of azoles and bromperidol" exact="derivatives" post="in the treatment of various fungal infections.Eur. J. Med."/>
 <result pre="increase of hydroxyl radicals.FEBS J.61327â€&quot;1338. 10.1111/j.1742-4658.2012.08527.x22324978 IngL. Y.ZinN. M.SarwarA.KatasH. (2012)." exact="Antifungal" post="activity of chitosan nanoparticles and correlation with their physical"/>
 <result pre="their physical properties.Int. J. Biomater.20121â€&quot;9. 10.1155/2012/63269822829829 JaneczkoM.KubiÅ&quot;skiK.MartynaA.MuzyczkaA.Boguszewska-CzubaraA.CzernikS.et al. (2018). 1,4-Naphthoquinone" exact="derivatives" post="potently suppress Candida albicans growth, inhibit formation of hyphae"/>
 <result pre="al. (2020). Drug repurposing of haloperidol: discovery of new benzocyclane" exact="derivatives" post="as potent antifungal agents against Cryptococcosis and Candidiasis.ACS Infect."/>
 <result pre="repurposing of haloperidol: discovery of new benzocyclane derivatives as potent" exact="antifungal" post="agents against Cryptococcosis and Candidiasis.ACS Infect. Dis.6768â€&quot;786. 10.1021/acsinfecdis.9b0019731550886 JiaW.ZhangH.LiC.LiG.LiuX.WeiJ."/>
 <result pre="of haloperidol: discovery of new benzocyclane derivatives as potent antifungal" exact="agents" post="against Cryptococcosis and Candidiasis.ACS Infect. Dis.6768â€&quot;786. 10.1021/acsinfecdis.9b0019731550886 JiaW.ZhangH.LiC.LiG.LiuX.WeiJ. (2016)."/>
 <result pre="tertiary hospital in india.J. Mycol.27171â€&quot;172. KeniyaM. V.FleischerE.KlingerA.CannonR. D.MonkB. C. (2015)." exact="Inhibitors" post="of the Candida albicans major facilitator superfamily transporter Mdr1p"/>
 <result pre="infections of medical devices.Clin. Microbiol. Rev.17255â€&quot;267. 10.1128/CMR.17.2.255-267.200415084500 KongF.WangJ.HanR.JiS.YueJ.WangY.et al. (2020)." exact="Antifungal" post="activity of magnesium oxide nanoparticles: effect on the growth"/>
 <result pre="D.DiamondS. L.LewisK. (2011). Novel high-throughput screen against Candida albicans identifies" exact="antifungal" post="potentiators and agents effective against biofilms.J. Antimicrob. Chemother.66820â€&quot;826. 10.1093/jac/dkq53021393183"/>
 <result pre="Novel high-throughput screen against Candida albicans identifies antifungal potentiators and" exact="agents" post="effective against biofilms.J. Antimicrob. Chemother.66820â€&quot;826. 10.1093/jac/dkq53021393183 LaraH. H.Ixtepan-TurrentL.YacamanM. J.Lopez-RibotJ."/>
 <result pre="biofilms?: an ultrastructural study.J. Nanobiotechnol.13:91. 10.1186/s12951-015-0147-826666378 LeeJ.LeeD. G. (2015). Novel" exact="antifungal" post="mechanism of resveratrol: apoptosis inducer in Candida albicans.Curr. Microbiol.70383â€&quot;389."/>
 <result pre="by liverwort derived Riccardin D.PLoS One7:e35543. 10.1371/journal.pone.003554322545115 LiuX.WangD.YuC.LiT.LiuJ.SunS. (2016). Potential" exact="antifungal" post="targets against a candida biofilm based on an enzyme"/>
 <result pre="of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves" exact="antifungal" post="effect against planktonic cells and biofilm of drug-resistant Candida"/>
 <result pre="MahT. F. C.Oâ€™TooleG. A. (2001). Mechanisms of biofilm resistance to" exact="antimicrobial" post="agents.Trends Microbiol.934â€&quot;39. 10.1016/S0966-842X(00)01913-211166241 Mahamuni-BadigerP. P.PatilP. M.BadigerM. V.PatelP. R.Thorat- GadgilB."/>
 <result pre="virulence properties of Candida albicans.Mycoses54e801â€&quot;e806. 10.1111/j.1439-0507.2011.02028.x21615543 MichaelC. A.Dominey-howesD.LabbateM. (2014). The" exact="antimicrobial" post="resistance crisis?: causes, consequences, and management.Front. Public Health2:145. 10.3389/fpubh.2014.0014525279369"/>
 <result pre="(2012). Silver nanoparticles: influence of stabilizing agent and diameter on" exact="antifungal" post="activity against Candida albicans and Candida glabrata biofilms.Lett. Appl."/>
 <result pre="10.1016/j.cell.2011.10.04822265407 NorrisL. A. B.KablaouiF.BrilhartM. K.BookstaverP. B. (2017). Systematic review of" exact="antimicrobial" post="lock therapy for prevention of central-line-associated bloodstream infections in"/>
 <result pre="Invasive candidiasis.Nat. Rev. Dis. Prim.4:18026. 10.1038/nrdp.2018.2629749387 PerfectJ. R. (2017). The" exact="antifungal" post="pipeline: a reality check.Nat. Rev. Drug Discov.16603â€&quot;616. 10.1038/nrd.2017.4628496146 PerlrothJ.ChoiB.SpellbergB."/>
 <result pre="problem.FEMS Yeast Res.6979â€&quot;986. 10.1111/j.1567-1364.2006.00117.x17042747 RamageG.RobertsonS. N.WilliamsC. (2014). Strength in numbers:" exact="antifungal" post="strategies against fungal biofilms.Int. J. Antimicrob. Agents43114â€&quot;120. 10.1016/j.ijantimicag.2013.10.02324359842 RamageG.SavilleS."/>
 <result pre="biofilm.Mol. Med. Rep.193201â€&quot;3209. 10.3892/mmr.2019.998130816484 SeddighiN. S.SalariS.IzadiA. R. (2017). Evaluation of" exact="antifungal" post="effect of ironâˆ’oxide nanoparticles against different Candida species.IET Nanobiotechnol.11883â€&quot;888."/>
 <result pre="acid: an in vitro investigation of a novel membrane active" exact="antiseptic" post="agent against Candida albicans biofilms.Front. Microbiol.3:116. 10.3389/fmicb.2012.0011622479260 ShuklaA. K."/>
 <result pre="biofilm inhibitors.Antimicrob. Agents Chemother.573681â€&quot;3687. 10.1128/AAC.00680-1323689719 SilvaF.FerreiraS.DuarteA.MendoncD. I.DominguesF. C. (2011). Phytomedicine" exact="antifungal" post="activity of Coriandrum sativum essential oil, its mode of"/>
 <result pre="amphotericin B.Phytomedicine1942â€&quot;47. 10.1016/j.phymed.2011.06.03321788125 SilvaS.RodriguesC. F.AraÃºjoD.RodriguesM. E.HenriquesM. (2017). Candida species biofilmsâ€™" exact="antifungal" post="resistance.J. Fungi3:8. 10.3390/jof301000829371527 SimsekM.DumanR. (2017). Investigation of effect of"/>
 <result pre="Fungi3:8. 10.3390/jof301000829371527 SimsekM.DumanR. (2017). Investigation of effect of 1,8-cineole on" exact="antimicrobial" post="activity of chlorhexidine gluconate.Pharmacognosy Res.9:234. 10.4103/0974-8490.21032928827963 SollD. R.DanielsK. J."/>
 <result pre="Candida infections, causes, targets, and resistance mechanisms: traditional and alternative" exact="antifungal" post="agents.Biomed Res. Int.204237. 10.1155/2013/20423723878798 SpormannA. M.ThormannK.SavilleR.ShuklaS.EntchevaP. (2004). Microbial biofilms.Nanoscale"/>
 <result pre="10.1201/9780203500224 SuH.HanL.HuangX. (2018). Potential targets for the development of new" exact="antifungal" post="drugs.J. Antibiot.71978â€&quot;991. 10.1038/s41429-018-0100-930242283 SubbiahdossG.PidhatikaB.CoullerezG.CharnleyM.KuijerR.van der MeiH.et al. (2010). Bacterial"/>
 <result pre="Cells Mater.19205â€&quot;213. 10.22203/ecm.v019a2020467966 SunB.ZhangM.LiY.HuQ.ZhengH.ChangW.et al. (2016). Synthesis of riccardin D" exact="derivatives" post="as potent antimicrobial agents.Bioorg. Med. Chem. Lett.263617â€&quot;3620. 10.1016/j.bmcl.2016.06.00627297569 SunL.LiaoK.WangD."/>
 <result pre="SunB.ZhangM.LiY.HuQ.ZhengH.ChangW.et al. (2016). Synthesis of riccardin D derivatives as potent" exact="antimicrobial" post="agents.Bioorg. Med. Chem. Lett.263617â€&quot;3620. 10.1016/j.bmcl.2016.06.00627297569 SunL.LiaoK.WangD. (2015). Effects of"/>
 <result pre="Mycol.59:myaa058. 10.1093/mmy/myaa05832658959 ThangamaniS.EldesoukyH. E.MohammadH.PascuzziP. E.AvramovaL.HazbunT. R.et al. (2017). Ebselen exerts" exact="antifungal" post="activity by regulating glutathione (GSH) and reactive oxygen species"/>
 <result pre="fungal cells.Biochim. Biophys. Acta Gen. Subj.18613002â€&quot;3010. 10.1016/j.bbagen.2016.09.02927712973 TianH.QuS.WangY.LuZ.ZhangM.GanY.et al. (2017)." exact="Calcium" post="and oxidative stress mediate perillaldehyde-induced apoptosis in Candida albicans.Appl."/>
 <result pre="Candida albicans to uncover mechanism of action of a novel" exact="antifungal" post="agent.Front. Cell Infect. Microbiol.8:164. 10.3389/fcimb.2018.0016429938200 TsuiC.KongE. F.Jabra-RizkM. A. (2016)."/>
 <result pre="multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for" exact="antifungal" post="drug development.Antimicrob. Agents Chemother.62:e01084-18. 10.1128/AAC.01084-1830104269 WangB.YouJ.KingJ. B.CaiS.ParkE.PowellD. R.et al."/>
 <result pre="(2014). In vitro and in vivo activity of a novel" exact="antifungal" post="small molecule against Candida Infections.PLoS One9:e85836. 10.1371/journal.pone.008583624465737 collab: World"/>
 <result pre="Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the" exact="antifungal" post="activity of Amphotericin B against clinical candida isolates.ACS Chem."/>
</results>
